Free Trial

Invesco Pharmaceuticals ETF Rating

$82.67 +0.31 (+0.38%)
(As of 12/20/2024 04:33 PM ET)

Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

PJP Aggregate Rating

Moderate Buy
2.69

Holdings in PJP have an aggregate rating of Moderate Buy based on 369 analyst ratings issued in the past year covering 30 companies (99.9% of the portfolio).

PJP Aggregate Price Target

$82.67
High Prediction$82.67
Average Prediction$82.67
Low Prediction$82.67

Holdings in PJP have an aggregate price target of $82.67 and a range of $82.67 to $82.67 covering 30 companies (99.9% of the portfolio).

PJP Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
Moderate Buy
18 Moderate Buy rating(s)
Hold
5 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Invesco Pharmaceuticals ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 30 PJP Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
5.27%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$767.76
+1.3%
4.9933 of 5 stars
2.81$1,002.22 30.5%21Gap Up
High Trading Volume
5.16%
Pfizer Inc. stock logo
PFE
Pfizer
$26.36
+2.3%
4.9696 of 5 stars
2.47$32.14 21.9%17Analyst Forecast
Options Volume
Analyst Revision
High Trading Volume
5.06%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$98.05
-1.5%
4.9889 of 5 stars
2.71$127.13 29.7%21Analyst Downgrade
High Trading Volume
5.06%
AbbVie Inc. stock logo
ABBV
AbbVie
$175.58
+2.4%
4.937 of 5 stars
2.88$205.70 17.2%24Analyst Forecast
Insider Trade
High Trading Volume
5.02%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$57.33
+1.8%
4.7851 of 5 stars
2.25$55.64 -2.9%20High Trading Volume
4.90%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$114.23
+1.6%
4.9133 of 5 stars
2.73$130.71 14.4%15Dividend Increase
High Trading Volume
4.81%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$144.47
+0.6%
4.8599 of 5 stars
2.50$174.73 20.9%14High Trading Volume
4.63%
Amgen Inc. stock logo
AMGN
Amgen
$263.38
+0.8%
4.4625 of 5 stars
2.40$319.67 21.4%25Analyst Downgrade
Gap Up
High Trading Volume
3.07%
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
$52.91
+1.8%
0.3891 of 5 stars
3.00$54.20 2.4%7Gap Down
2.87%
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$359.58
-0.2%
4.7079 of 5 stars
2.73$370.86 3.1%15Analyst Downgrade
Insider Trade
High Trading Volume
2.86%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$92.57
+1.6%
4.4195 of 5 stars
2.67$96.43 4.2%27Insider Trade
High Trading Volume
2.80%
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
$29.70
-2.4%
3.946 of 5 stars
2.60$42.60 43.4%5News Coverage
Positive News
High Trading Volume
2.80%
Supernus Pharmaceuticals, Inc. stock logo
SUPN
Supernus Pharmaceuticals
$35.43
-1.0%
2.1946 of 5 stars
2.50$36.00 1.6%2High Trading Volume
2.80%
Liquidia Co. stock logo
LQDA
Liquidia
$11.10
+4.8%
3.2803 of 5 stars
3.11$25.38 128.6%9Analyst Forecast
News Coverage
High Trading Volume
2.78%
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
$114.64
+0.6%
4.9822 of 5 stars
3.00$147.00 28.2%6Analyst Revision
High Trading Volume
2.77%
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$8.50
+0.6%
3.6483 of 5 stars
2.86$16.71 96.6%7News Coverage
Positive News
2.75%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$701.85
-0.9%
4.6604 of 5 stars
2.70$1,052.90 50.0%23Analyst Forecast
High Trading Volume
2.75%
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$122.97
+0.1%
4.8615 of 5 stars
2.87$177.00 43.9%15High Trading Volume
2.70%
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
$34.28
+1.2%
4.7853 of 5 stars
2.60$49.80 45.3%10Analyst Forecast
Analyst Revision
High Trading Volume
2.69%
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
$7.78
+0.4%
3.0374 of 5 stars
2.80$10.00 28.5%5Analyst Downgrade
News Coverage
2.67%
Innoviva, Inc. stock logo
INVA
Innoviva
$17.84
-0.5%
2.0043 of 5 stars
3.001Positive News
High Trading Volume
2.67%
Geron Co. stock logo
GERN
Geron
$3.49
-4.6%
3.8526 of 5 stars
3.09$7.15 104.9%11Short Interest ↓
High Trading Volume
2.66%
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$53.35
-1.7%
4.8429 of 5 stars
3.00$77.71 45.7%8Insider Trade
Positive News
High Trading Volume
2.65%
Biogen Inc. stock logo
BIIB
Biogen
$146.47
-0.6%
4.6279 of 5 stars
2.45$242.68 65.7%29Analyst Downgrade
High Trading Volume
2.65%
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
$78.72
+0.1%
3.7945 of 5 stars
2.50$85.25 8.3%4Analyst Upgrade
Positive News
High Trading Volume
2.63%
Viatris Inc. stock logo
VTRS
Viatris
$12.52
+3.2%
1.8728 of 5 stars
2.00$13.67 9.2%3News Coverage
High Trading Volume
2.63%
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$17.18
-1.3%
2.5867 of 5 stars
2.92$23.67 37.8%12Positive News
High Trading Volume
2.61%
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$51.40
+0.5%
4.851 of 5 stars
3.00$65.25 26.9%5Analyst Revision
High Trading Volume
2.59%
Perrigo Company plc stock logo
PRGO
Perrigo
$25.75
+0.1%
4.9874 of 5 stars
2.75$37.00 43.7%4Positive News
2.55%
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$39.14
-0.6%
4.8265 of 5 stars
2.50$60.33 54.1%4High Trading Volume

This page (NYSEARCA:PJP) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners